The post-covid digital health boom saw European startups in the sector pick up $7.3bn across 2021 and 2022, according to Dealroom — more than the previous six years combined.
And while funding has tailed off in 2023 amid a wider tech downturn — digital health startups have raised just $783m so far this year — a number of promising scaleups are still convincing VCs to open their wallets and growing their businesses.
Sifted has used data from Dealroom to earmark nine digital health startups that could go on to hit unicorn status in the future. Each company was founded after 2005, raised its most recent round in 2020 or later and had a Dealroom valuation between $350m-999m.
